Wednesday, October 20, 2021
67.2 F
Fort Worth

Huntsman Cancer Institute joins Caris Life Science’ Precision Oncology Alliance

🕐 2 min read

Caris Life Sciences has announced that Huntsman Cancer Institute (HCI) at the University of Utah has joined Caris’ Precision Oncology Alliance, a collaborative network of leading cancer centers that work together to advance comprehensive cancer profiling and establish standards of care for molecular testing in oncology through research focused on predictive and prognostic markers that improve the clinical outcomes of patients with cancer.

HCI’s campus in Salt Lake City spans more than 1 million square feet of contiguous state-of-the-art cancer research and care space. Utilizing a team approach to cancer care, HCI has more than 200 research teams that study all aspects of cancer.
More genes for inherited cancers have been discovered at HCI than at any other cancer center in the world.
These include genes responsible for hereditary breast, ovarian, colon, head and neck cancers, and melanoma, Caris said in a news release.

HCI is the only National Cancer Institute-designated Comprehensive Cancer Center in the Mountain West, and serves the largest geographic region of all centers, covering Utah, Idaho, Montana, Nevada, and Wyoming.

“Huntsman Cancer Institute is a nationally recognized cancer center, known for utilizing coordinated, transdisciplinary innovative research to achieve a shared and common goal – defeating cancer,” said Chadi Nabhan, M.D., MBA, FACP, Chairman of the Caris Precision Oncology Alliance. “HCI’s focus on research in targeted therapies will amplify the POA’s goal to promote broad-based collaboration among our member institutions in precision oncology research to improve outcomes of all patients with cancer.”

“Huntsman Cancer Institute is laser focused on advancing understanding of the way cancer behaves, as these insights help us better understand how to prevent or treat this disease,” said Dr. Cornelia Ulrich, MS, Ph.D., Executive Director of the Comprehensive Cancer Center at HCI. “Understanding the unique molecular characteristics of tumors is one way we can accelerate these efforts and advance the promise of precision medicine.”

The Caris Precision Oncology Alliance includes more than 40 cancer centers and academic institutions. These institutions have early access to Caris MAI (Molecular Artificial Intelligence) offerings, and establish evidence-based standards for cancer profiling and molecular testing in oncology.

“Collaboration with nationally ranked cancer centers like the Huntsman Cancer Institute furthers new developments in cancer research that ultimately promote the discovery of more precise and better treatments for cancer patients at every member institution,” said Brian J. Brille, Vice Chairman of Caris Life Sciences.
www.CarisLifeSciences.com/collaboration

Related Articles

Our Digital Sponsors

Latest Articles

Texas Rangers
Fort Worth Business Press Logo
This advertisement will close in
00
Months
00
Days
00
Hours
00
Minutes
00
Seconds
seconds..
Click here to continue to Fort Worth Business Press

Not ready to subscribe?

Try a few articles on us.

Enter your email address and we will give you access to three articles a month, to give us a try. You also get an opportunity to receive our newsletter with stories of the day.

This field is for validation purposes and should be left unchanged.

Get our email updates

Stay up-to-date with the issues, companies and people that matter most to business in the Fort Worth.

  • Restaurants
  • Technology
  • and more!

FWBP Morning Brief

FWBP 5@5

Weekend Newsletter

  • Banking & Finance
  • Culture
  • Real Estate